CA2075163A1 - A87689 compounds - Google Patents

A87689 compounds

Info

Publication number
CA2075163A1
CA2075163A1 CA002075163A CA2075163A CA2075163A1 CA 2075163 A1 CA2075163 A1 CA 2075163A1 CA 002075163 A CA002075163 A CA 002075163A CA 2075163 A CA2075163 A CA 2075163A CA 2075163 A1 CA2075163 A1 CA 2075163A1
Authority
CA
Canada
Prior art keywords
compound
compounds
nrrl
cells
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002075163A
Other languages
English (en)
French (fr)
Inventor
Dennis R. Berry
Joseph M. Colacino
Anne H. Dantzig
Manuel Debono
Robert L. Hamill
Robert M. Molloy, Sr.
Joseph C. Tang
Che-Fong Yao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2075163A1 publication Critical patent/CA2075163A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002075163A 1991-08-01 1992-07-31 A87689 compounds Abandoned CA2075163A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73896991A 1991-08-01 1991-08-01
US07/738,969 1991-08-01
US88972292A 1992-05-28 1992-05-28
US07/889,722 1992-05-28

Publications (1)

Publication Number Publication Date
CA2075163A1 true CA2075163A1 (en) 1993-02-02

Family

ID=27113454

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002075163A Abandoned CA2075163A1 (en) 1991-08-01 1992-07-31 A87689 compounds

Country Status (14)

Country Link
EP (1) EP0526258A2 (enExample)
JP (1) JPH05213999A (enExample)
KR (1) KR930004460A (enExample)
CN (1) CN1073979A (enExample)
AU (1) AU2072092A (enExample)
BR (1) BR9202993A (enExample)
CA (1) CA2075163A1 (enExample)
CZ (1) CZ233892A3 (enExample)
FI (1) FI923487L (enExample)
HU (1) HUT65398A (enExample)
IL (1) IL102679A0 (enExample)
MX (1) MX9204419A (enExample)
NO (1) NO923029L (enExample)
YU (1) YU75192A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055814A1 (en) * 2010-10-25 2012-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910002457A (ko) * 1989-07-10 1991-02-25 원본미기재 항 비루스 항생제 bu-3889v

Also Published As

Publication number Publication date
CN1073979A (zh) 1993-07-07
MX9204419A (es) 1993-02-01
FI923487A0 (fi) 1992-07-31
BR9202993A (pt) 1993-03-30
HU9202478D0 (en) 1992-10-28
CZ233892A3 (en) 1993-02-17
IL102679A0 (en) 1993-01-14
AU2072092A (en) 1993-02-04
EP0526258A2 (en) 1993-02-03
KR930004460A (ko) 1993-03-22
JPH05213999A (ja) 1993-08-24
YU75192A (sh) 1995-10-03
HUT65398A (en) 1994-06-28
FI923487A7 (fi) 1993-02-02
EP0526258A3 (enExample) 1994-04-27
NO923029L (no) 1993-02-02
NO923029D0 (no) 1992-07-31
FI923487L (fi) 1993-02-02

Similar Documents

Publication Publication Date Title
US6596518B2 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
US4870165A (en) Antifungal antibiotics
BG61205B2 (bg) Хипохолестеринови ферментационни продукти и метод за получаването им
AU3767993A (en) FO-1289 substance and its production
AOYAGI et al. Cyclooctatin, a new inhibitor of lysophospholipase, produced by Streptomyces melanosporofaciens Mi614-43F2 taxonomy, production, isolation, physico-chemical properties and biological activities
US5350579A (en) A87689 compounds employed as a phospholipase A2 (PLA2) inhibitor to treat inflammatory diseases
JPH06234693A (ja) 新規イソテトラセノン系物質及びその製造法
US5250563A (en) Inhibitors of HIV protease
US5278064A (en) Amycolatopsis mediterranei strains useful to prepare A87689 compounds
JPH0521909B2 (enExample)
JPH029381A (ja) 抗生物質
US6432978B1 (en) SF2809-I,II,III,IV,V and VI substances exhibiting chymase-inhibiting activities
US4545991A (en) Difficidin and derivative antibacterials
CA2075163A1 (en) A87689 compounds
US5286649A (en) Antiviral antibiotic BU-3889V
US5098708A (en) Antiviral antibiotic BU-3889V
US5061730A (en) Carboxylic acid derivatives
AU779352B2 (en) Aromatic di-keto derivatives, processes for their production and their use as a pharmaceutical
US4780311A (en) Antihypercholesterolemic tri-yne carbonates
US4681846A (en) Process for the preparation of difficidin and derivative antibacterials
EP0253413A2 (en) New antibiotics called "mureidomycins A, B, C and D" A process for their preparation and their therapeutic use
PT88523B (pt) Processo para a producao de um antibiotico glicopeptidico
US5124150A (en) Process for preparing antiviral antibiotic BU-3889V
EP0808843B1 (en) Novel macrolide compound 0406
KR20040025902A (ko) Ｃｎｓ 장애 치료용 의약의 제조시 티오루틴 디옥사이드및 이의 유도체의 용도 및 이의 제조방법

Legal Events

Date Code Title Description
FZDE Discontinued